{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:43Z","timestamp":1772165923299,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81372163"],"award-info":[{"award-number":["No. 81372163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Sci-Tech Special Project of China","award":["No.2018ZX10302207"],"award-info":[{"award-number":["No.2018ZX10302207"]}]},{"name":"Technology Planning Project of Guilin","award":["No. 20190218-1"],"award-info":[{"award-number":["No. 20190218-1"]}]},{"name":"Basic Ability Enhancement Program for Young and Middle\u2011aged Teachers of Guilin Medical University","award":["No. 2018glmcy073"],"award-info":[{"award-number":["No. 2018glmcy073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most hepatocellular carcinoma (HCC) patients\u2019 liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase\u2009+\u2009gamma-glutamyl transpeptidase)\/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 495 HCC patients undergoing radical hepatectomy were retrospectively analyzed. We randomly divided these patients into the training cohort (n\u2009=\u2009248) and the validation cohort (n\u2009=\u2009247). In the training cohort, receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of AGLR for predicting postoperative survival of HCC patients, and the predictive value of AGLR was evaluated by concordance index (C-index). Further analysis of clinical and biochemical data of patients and the correlation analysis between AGLR and other clinicopathological factors were finished. Univariate and multivariate analyses were performed to identify prognostic factors for HCC patients. Survival curves were analyzed using the Kaplan\u2013Meier method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to the ROC curve analysis, the optimal predictive cut-off value of AGLR was 90. The C-index of AGLR was 0.637 in the training cohort and 0.654 in the validation cohort, respectively. Based on this value, the HCC patients were divided into the low-AGLR group (AGLR\u2009\u2264\u200990) and the high-AGLR group (AGLR\u2009&gt;\u200990). Preoperative AGLR level was positively correlated with alpha-fetoprotein (AFP), tumor size, tumor-node-metastasis (TNM) stage, and microvascular invasion (MVI) (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In the training and validation cohorts, patients with AGLR\u2009&gt;\u200990 had significantly shorter OS than patients with AGLR\u2009\u2264\u200990 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Univariate and multivariate analyses of the training cohort (HR, 1.79; 95% CI 1.21\u20132.69;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and validation cohort (HR, 1.82; 95% CI 1.35\u20132.57;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) had identified AGLR as an independent prognostic factor. A new prognostic scoring model was established based on the independent predictors determined in multivariate analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The elevated preoperative AGLR level indicated poor prognosis for patients with HCC; the novel prognostic scoring model had favorable predictive capability for postoperative prognosis of HCC patients, which may bring convenience for clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-020-01037-7","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T12:03:13Z","timestamp":1612353793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Yan","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-8612","authenticated-orcid":false,"given":"Weijia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1037_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118\u201327.","journal-title":"N Engl J Med"},{"key":"1037_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jhep.2015.10.029","volume":"64","author":"PH Liu","year":"2016","unstructured":"Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, et al. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. J Hepatol. 2016;64:601\u20138.","journal-title":"J Hepatol"},{"key":"1037_CR4","doi-asserted-by":"publisher","first-page":"28835","DOI":"10.1038\/srep28835","volume":"6","author":"SJ Fu","year":"2016","unstructured":"Fu SJ, Zhao Q, Ji F, Chen MG, Wu LW, Ren QQ, et al. Elevated preoperative serum gamma-glutamyl transpeptidase predicts poor prognosis for hepatocellular carcinoma after liver transplantation. Sci Rep. 2016;6:28835.","journal-title":"Sci Rep"},{"key":"1037_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijsu.2018.07.011","volume":"57","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xu D, Zhang Z, Dong J, Zhou Y, Zhang WW, et al. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma. Int J Surg. 2018;57:45\u201353.","journal-title":"Int J Surg"},{"key":"1037_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fonc.2019.00347","volume":"9","author":"MJ Liao","year":"2019","unstructured":"Liao MJ, Qin WY, Liao Y, Yao RZ, Yu JX, Liao WJ. Prognostic value of gamma-glutamyl transpeptidase to lymphocyte count ratio in patients with single tumor size \u2264 5 cm hepatocellular carcinoma after radical resection. Front Oncol. 2019;9:347.","journal-title":"Front Oncol"},{"key":"1037_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/COC.0000000000000619","volume":"43","author":"J Huang","year":"2020","unstructured":"Huang J, Liu FC, Li L, Yuan SX, Yang Y, Jiang BG, et al. Prognostic nomogram for hepatitis B Virus-related hepatocellular carcinoma with adjuvant transarterial chemoembolization after radical resection. Am J Clin Oncol. 2020;43:20\u20137.","journal-title":"Am J Clin Oncol"},{"key":"1037_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/CCLM.2010.052","volume":"48","author":"M Webber","year":"2010","unstructured":"Webber M, Krishnan A, Thomas NG, Cheung BM. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005\u20132006. Clin Chem Lab Med. 2010;48:167\u201373.","journal-title":"Clin Chem Lab Med"},{"key":"1037_CR9","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.bbadis.2013.07.016","volume":"1832","author":"AF Pike","year":"2013","unstructured":"Pike AF, Kramer NI, Blaauboer BJ, Seinen W, Brands R. A novel hypothesis for an alkaline phosphatase \u201crescue\u201d mechanism in the hepatic acute phase immune response. Biochim Biophys Acta. 2013;1832:2044\u201356.","journal-title":"Biochim Biophys Acta"},{"key":"1037_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ije\/dyt192","volume":"43","author":"SK Kunutsor","year":"2014","unstructured":"Kunutsor SK, Apekey TA, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:187\u2013201.","journal-title":"Int J Epidemiol"},{"key":"1037_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5732\/cjc.011.10283","volume":"31","author":"G Li","year":"2012","unstructured":"Li G, Gao J, Tao YL, Xu BQ, Tu ZW, Liu ZG, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer. 2012;31:197\u2013206.","journal-title":"Chin J Cancer"},{"key":"1037_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10620-006-9345-4","volume":"51","author":"TE Clancy","year":"2006","unstructured":"Clancy TE, Sengupta TP, Paulus J, Ahmed F, Duh MS, Kulke MH. Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors. Dig Dis Sci. 2006;51:877\u201384.","journal-title":"Dig Dis Sci"},{"key":"1037_CR13","doi-asserted-by":"publisher","first-page":"e4065","DOI":"10.1097\/MD.0000000000004065","volume":"95","author":"F Ji","year":"2016","unstructured":"Ji F, Fu SJ, Guo ZY, Pang H, Ju WQ, Wang DP, et al. Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma. Medicine (Baltimore). 2016;95:e4065.","journal-title":"Medicine (Baltimore)"},{"key":"1037_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s007950300006","volume":"36","author":"K Yamamoto","year":"2003","unstructured":"Yamamoto K, Awogi T, Okuyama K, Takahashi N. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med Electron Microsc. 2003;36:47\u201351.","journal-title":"Med Electron Microsc"},{"key":"1037_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342:1266\u201371.","journal-title":"N Engl J Med"},{"key":"1037_CR16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10529-019-02743-w","volume":"41","author":"J Jiao","year":"2019","unstructured":"Jiao J, Zhao X, Hou R, Wang Y, Chang W, Liang N, et al. Comparison of two commonly used methods for stimulating T cells. Biotechnol Lett. 2019;41:1361\u201371.","journal-title":"Biotechnol Lett"},{"key":"1037_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhep.2005.12.027","volume":"45","author":"E Unitt","year":"2006","unstructured":"Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol. 2006;45:246\u201353.","journal-title":"J Hepatol"},{"key":"1037_CR18","doi-asserted-by":"publisher","first-page":"e1273309","DOI":"10.1080\/2162402X.2016.1273309","volume":"6","author":"K Sideras","year":"2017","unstructured":"Sideras K, Biermann K, Verheij J, Takkenberg BR, Mancham S, Hansen BE, et al. PD-L1, Galectin-9 and CD8 tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma. Oncoimmunology. 2017;6:e1273309.","journal-title":"Oncoimmunology"},{"key":"1037_CR19","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3748\/wjg.v20.i31.10944","volume":"20","author":"XS Xu","year":"2014","unstructured":"Xu XS, Wan Y, Song SD, Chen W, Miao RC, Zhou YY, et al. Model based on \u03b3-glutamyl transferase and alkaline phosphatase for hepatocellular carcinoma prognosis. World J Gastroenterol. 2014;20:10944\u201352.","journal-title":"World J Gastroenterol"},{"key":"1037_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jcmm.12745","volume":"20","author":"Y Lu","year":"2016","unstructured":"Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med. 2016;20:549\u201358.","journal-title":"J Cell Mol Med"},{"key":"1037_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"J Bruix","year":"2014","unstructured":"Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63:844\u201355.","journal-title":"Gut"},{"key":"1037_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","volume":"29","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29:610\u20138.","journal-title":"J Clin Oncol"},{"key":"1037_CR23","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1182\/blood-2012-05-430389","volume":"120","author":"AM Perry","year":"2012","unstructured":"Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, et al. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2012;120:2290\u20136.","journal-title":"Blood"},{"key":"1037_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nm1377","volume":"12","author":"JS Lee","year":"2006","unstructured":"Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006;12:410\u20136.","journal-title":"Nat Med"},{"key":"1037_CR25","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.3748\/wjg.v22.i21.5088","volume":"22","author":"HJ Yang","year":"2016","unstructured":"Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World J Gastroenterol. 2016;22:5088\u201395.","journal-title":"World J Gastroenterol"},{"key":"1037_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1159\/000485396","volume":"44","author":"J Zheng","year":"2017","unstructured":"Zheng J, Cai J, Li H, Zeng K, He L, Fu H, et al. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review. Cell Physiol Biochem. 2017;44:967\u201381.","journal-title":"Cell Physiol Biochem"},{"key":"1037_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/liv.14249","volume":"40","author":"SY Ho","year":"2020","unstructured":"Ho SY, Hsu CY, Liu PH, Hsia CY, Lei HJ, Huang YH, et al. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma. Liver Int. 2020;40:205\u201314.","journal-title":"Liver Int"},{"key":"1037_CR28","doi-asserted-by":"publisher","first-page":"584871","DOI":"10.3389\/fmed.2020.584871","volume":"7","author":"J Pan","year":"2020","unstructured":"Pan J, Chen S, Tian G, Jiang T. Preoperative Albumin-Bilirubin Grade With Prognostic Nutritional Index Predicts the Outcome of Patients With Early-Stage Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation. Front Med (Lausanne). 2020;7:584871.","journal-title":"Front Med (Lausanne)"},{"key":"1037_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3389\/fonc.2019.00817","volume":"9","author":"J Shen","year":"2019","unstructured":"Shen J, Tang L, Zhang X, Peng W, Wen T, Li C, et al. A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR). Front Oncol. 2019;9:817.","journal-title":"Front Oncol"},{"key":"1037_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","volume":"72","author":"G Berardi","year":"2020","unstructured":"Berardi G, Morise Z, Sposito C, Igarashi K, Panetta V, Simonelli I, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol. 2020;72:75\u201384.","journal-title":"J Hepatol"},{"key":"1037_CR31","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/cncr.30237","volume":"122","author":"SP Choo","year":"2016","unstructured":"Choo SP, Tan WL, Goh BKP, Tai WM, Zhu AX. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer. 2016;122:3430\u201346.","journal-title":"Cancer"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-01037-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12893-020-01037-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-01037-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T01:33:34Z","timestamp":1697765614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-020-01037-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1186\/s12893-020-01037-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-103565\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the research ethics committee of the Affiliated Hospital of Guilin Medical University and complied with the Declaration of Helsinki Principles. Written informed consent for treatment and use of their clinical data was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}